ENANTA PHARMACEUTICALS INC
ENTANASDAQ🏆 #3208 by market capEarnings Nov 16 · PostUS Equity
$12.64▲ $0.03 (+0.20%)
🌙 After hours$12.64▲ 0.00%Regular close · extended-hours price shownTrack ENTA
Get earnings, price moves & breaking news on Telegram
24h▲ 0.2%
7d▲ 5.7%
14d▼ 0.7%
30d▼ 5.0%
ytd▼ 20.3%
1y▲ 5.5%
🏦Market Cap
$368M
Small Cap
📈Revenue Growth (YoY)
-3.4%
Declining
📊Gross Margin
98.2%
High
💵FCF Margin
-56.6%
Thin
⚖️P/S Ratio
5.6x
Fair
Otter Score
68
Fair
ENANTA PHARMACEUTICALS INC
ENTAAnalyst Ratings
Price
$12.64
Total
19
Raised
1
Lowered
0
Avg PT
$20.00
H / L
$20 / $20
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-23 | — | — |
Jefferies | Upgraded | Hold → Buy | 2025-10-01 | $20.00 | +58.20% |
WestPark Capital | Reiterated | Buy | 2025-09-30 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2025-09-15 | — | — |
JMP Securities | Reiterated | Market Outperform | 2025-08-12 | $24.00 | +89.90% |
Baird | Reiterated | Outperform | 2024-11-26 | — | — |
JP Morgan | Reiterated | Underweight | 2024-08-06 | — | — |
Oppenheimer | Reiterated | Perform | 2023-11-22 | — | — |
RBC Capital | Reiterated | Sector Perform | 2023-10-02 | $54.00 | +327.20% |
SVB Leerink | Reiterated | Market Perform → Perform | 2023-02-09 | — | — |
Piper Sandler | Reiterated | Overweight | 2023-02-08 | $87.00 | +588.30% |
Roth Capital | Reiterated | Buy | 2022-05-12 | — | — |
Berenberg | Reiterated | Buy | 2018-12-13 | — | — |
Barclays | Reiterated | Underweight | 2016-02-09 | — | — |
Leerink Swann | Reiterated | Outperform | 2015-05-08 | — | — |
Deutsche Bank | Reiterated | Buy | 2015-04-06 | — | — |
FBR Capital | Reiterated | Outperform | 2014-10-21 | — | — |
Macquarie | Reiterated | Outperform | 2014-06-17 | — | — |
Credit Suisse | Reiterated | Outperform | 2013-04-15 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-23
—
—
Jefferies
Upgraded · Hold → Buy · 2025-10-01
$20.00
+58.20%
WestPark Capital
Reiterated · Buy · 2025-09-30
—
—
Evercore ISI Group
Reiterated · Outperform · 2025-09-15
—
—
JMP Securities
Reiterated · Market Outperform · 2025-08-12
$24.00
+89.90%
Baird
Reiterated · Outperform · 2024-11-26
—
—
JP Morgan
Reiterated · Underweight · 2024-08-06
—
—
Oppenheimer
Reiterated · Perform · 2023-11-22
—
—
RBC Capital
Reiterated · Sector Perform · 2023-10-02
$54.00
+327.20%
SVB Leerink
Reiterated · Market Perform → Perform · 2023-02-09
—
—
Piper Sandler
Reiterated · Overweight · 2023-02-08
$87.00
+588.30%
Roth Capital
Reiterated · Buy · 2022-05-12
—
—
Berenberg
Reiterated · Buy · 2018-12-13
—
—
Barclays
Reiterated · Underweight · 2016-02-09
—
—
Leerink Swann
Reiterated · Outperform · 2015-05-08
—
—
Deutsche Bank
Reiterated · Buy · 2015-04-06
—
—
FBR Capital
Reiterated · Outperform · 2014-10-21
—
—
Macquarie
Reiterated · Outperform · 2014-06-17
—
—
Credit Suisse
Reiterated · Outperform · 2013-04-15
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space